Home > Income Statement > VALIANT LABORATORIES

VALIANT LABORATORIES
Revenue

    Back to Income Statement
VALIANT LABORATORIES is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for VALIANT LABORATORIES
Please provide your vote to see the results

VALIANT LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Net Sales ₹237 Cr₹133 Cr₹182 Cr₹334 Cr

What is the latest Revenue of VALIANT LABORATORIES ?

The latest Revenue ratio of VALIANT LABORATORIES is ₹237 Cr based on Mar2026 Consolidated results.
Year Revenue
Mar2026₹237 Cr
Mar2025₹133 Cr
Mar2024₹182 Cr
Mar2023₹334 Cr

How is Revenue of VALIANT LABORATORIES Trending?

Years Revenue % Change
Mar2026 ₹237 Cr
78.04
Mar2025 ₹133 Cr
-26.74
Mar2024 ₹182 Cr
-45.48
Mar2023 ₹334 Cr -

Compare Revenue of peers of VALIANT LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
VALIANT LABORATORIES ₹657.3 Cr -5.6% -3.6% 50.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹426,122.0 Cr 0.7% -0.3% 3.2% Stock Analytics
DIVIS LABORATORIES ₹266,424.0 Cr 4% 8.9% 54.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹179,914.0 Cr 3.6% -0.5% 28.8% Stock Analytics
DR REDDYS LABORATORIES ₹114,599.0 Cr 2.5% 13.6% 9.4% Stock Analytics
CIPLA ₹113,112.0 Cr 3.2% 5% -11.9% Stock Analytics


VALIANT LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
VALIANT LABORATORIES

-5.6%

-3.6%

50.1%

SENSEX

5.5%

7.5%

-8.7%


You may also like the below Video Courses